Tidal Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Tidal Investments's NVS Position: Q2 2026 in Review
Tidal Investments reduced its Novartis (NVS) stake by 52% in Q2 2026, selling an estimated $15.2M and leaving 91,944 shares worth $14.4M. The position accounts for 0.02% of the portfolio, ranked #557.
Tidal Investments first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $38.7M in Q3 2025. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Tidal Investments held 91,944 shares of Novartis worth $14.4M as of Q2 2026.
- Tidal Investments sold 101,233 Novartis shares in Q2 2026, an estimated $15.2M.
- Novartis made up 0.02% of Tidal Investments's portfolio in Q2 2026, its #557 holding.
- Tidal Investments first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
- Tidal Investments's Novartis position peaked at $38.7M in Q3 2025.
- 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.